The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Table of contents


Chemical Compound Review

Biapenem     (4R,5R,6S)-3-(3,5-diaza-1...

Synonyms: Omegacin, PubChem5820, Omegacin (TN), SureCN49242, CHEMBL285347, ...
This record was replaced with 71340.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid


High impact information on (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid


Chemical compound and disease context of (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid


Biological context of (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid


Anatomical context of (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

  • The accumulation of neutrophils in the uterus in the biapenem- treated group was less marked than in the nontreated group, as well as bacteriological response [15].

Associations of (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid with other chemical compounds


Gene context of (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid


Analytical, diagnostic and therapeutic context of (4R,5R,6S)-3-(3,5-diaza-1-azoniabicyclo[3.3.0]octa-1,3-dien-7-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid


  1. Catalytic mechanism of class B2 metallo-beta-lactamase. Xu, D., Xie, D., Guo, H. J. Biol. Chem. (2006) [Pubmed]
  2. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties. Yang, Y., Testa, R.T., Bhachech, N., Rasmussen, B.A., Bush, K. Antimicrob. Agents Chemother. (1999) [Pubmed]
  3. Novel Pseudomonas aeruginosa gene that suppresses tolerance to carbapenems. Taniguchi, K., Ono, T., Murakami, K., Viducic, D., Kayama, S., Hirota, K., Nemoto, K., Miyake, Y. Antimicrob. Agents Chemother. (2003) [Pubmed]
  4. In vitro activities of aminomethyl-substituted analogs of novel tetrahydrofuranyl carbapenems. Weiss, W.J., Petersen, P.J., Jacobus, N.V., Lin, Y.I., Bitha, P., Testa, R.T. Antimicrob. Agents Chemother. (1999) [Pubmed]
  5. In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria. Malanoski, G.J., Collins, L., Wennersten, C., Moellering, R.C., Eliopoulos, G.M. Antimicrob. Agents Chemother. (1993) [Pubmed]
  6. A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem. Garau, G., Bebrone, C., Anne, C., Galleni, M., Frère, J.M., Dideberg, O. J. Mol. Biol. (2005) [Pubmed]
  7. Biapenem. Perry, C.M., Ibbotson, T. Drugs (2002) [Pubmed]
  8. Contribution of enzymatic properties, cell permeability, and enzyme expression to microbiological activities of beta-lactams in three Bacteroides fragilis isolates that harbor a metallo-beta-lactamase gene. Rasmussen, B.A., Yang, Y., Jacobus, N., Bush, K. Antimicrob. Agents Chemother. (1994) [Pubmed]
  9. Pharmacokinetics of a parenteral carbapenem, biapenem, in patients with end-stage renal disease and influence of haemodialysis. Nagashima, S., Kozawa, O., Otsuka, T., Kohno, K., Minamoto, M., Yokokawa, M., Kanamaru, M., Uematsu, T. J. Antimicrob. Chemother. (2000) [Pubmed]
  10. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. Yang, Y., Bhachech, N., Bush, K. J. Antimicrob. Chemother. (1995) [Pubmed]
  11. An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli. Horii, T., Kobayashi, M., Sato, K., Ichiyama, S., Ohta, M. J. Antimicrob. Chemother. (1998) [Pubmed]
  12. Comparative in-vitro activity of biapenem and other carbapenems against Haemophilus influenzae isolates with known resistance mechanisms to ampicillin. Yeo, S.F., Livermore, D.M. J. Antimicrob. Chemother. (1994) [Pubmed]
  13. Comparative in vitro activity of piperacillin/tazobactam against gram-negative bacilli. Liebowitz, L.D., Klugman, K.P. S. Afr. Med. J. (1996) [Pubmed]
  14. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance. Chen, H.Y., Livermore, D.M. J. Antimicrob. Chemother. (1994) [Pubmed]
  15. In vitro and in vivo antibacterial activities of biapenem in the fields of obstetrics and gynecology. Mikamo, H., Sato, Y., Hayasaki, Y., Tamaya, T. Chemotherapy. (2000) [Pubmed]
  16. Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa. Horii, T., Ichiyama, S., Ohta, M., Kobayashi, M. J. Med. Microbiol. (1999) [Pubmed]
  17. In vitro activity of beta-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics. Yamaguchi, T., Hashikita, G., Takahashi, S., Itabashi, A., Yamazaki, T., Maesaki, S. J. Infect. Chemother. (2005) [Pubmed]
  18. Interactions of biapenem with active-site serine and metallo-beta-lactamases. Felici, A., Perilli, M., Segatore, B., Franceschini, N., Setacci, D., Oratore, A., Stefani, S., Galleni, M., Amicosante, G. Antimicrob. Agents Chemother. (1995) [Pubmed]
  19. Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem. Mattoes, H.M., Kuti, J.L., Drusano, G.L., Nicolau, D.P. Clinical therapeutics. (2004) [Pubmed]
  20. Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. Bale, M.J., Jones, R.N., Erwin, M.E. Diagn. Microbiol. Infect. Dis. (1994) [Pubmed]
  21. Post-antibiotic effect of FK-037 and biapenem tested against five bacterial species. Houston, A.K., Jones, R.N. Journal of chemotherapy (Florence, Italy) (1994) [Pubmed]
  22. Activity of biapenem (LJC 10627) against 51 imipenem-resistant bacteria and selection and characterisation of biapenem-resistant mutants. Piddock, L.J., Jin, Y.F. J. Antimicrob. Chemother. (1995) [Pubmed]
  23. Role for rpoS gene of Pseudomonas aeruginosa in antibiotic tolerance. Murakami, K., Ono, T., Viducic, D., Kayama, S., Mori, M., Hirota, K., Nemoto, K., Miyake, Y. FEMS Microbiol. Lett. (2005) [Pubmed]
  24. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Chen, H.Y., Livermore, D.M. J. Antimicrob. Chemother. (1994) [Pubmed]
  25. In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide. Hoban, D.J., Jones, R.N., Yamane, N., Frei, R., Trilla, A., Pignatari, A.C. Diagn. Microbiol. Infect. Dis. (1993) [Pubmed]
  26. A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography. Ikeda, K., Ikawa, K., Ikeda, A., Nishikawa, Y., Morikawa, N. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2006) [Pubmed]
WikiGenes - Universities